SC 13G |
Report
|
SC 13G |
Aug 1, 2024 |
|
SC 13G |
Report
|
THE SCHEDULE 13G |
May 17, 2024 |
|
SC 13G |
Report
|
THE SCHEDULE 13G |
May 17, 2024 |
|
SC 13G/A |
Report
|
|
Feb 14, 2024 |
|
SC 13G/A |
Report
|
|
Feb 14, 2024 |
|
SC 13G/A |
Report
|
PIERIS PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 2 TO SCHEDULE 13G |
Feb 2, 2024 |
|
SC 13G |
Report
|
|
Jun 12, 2023 |
|
SC 13G/A |
Report
|
PIERIS PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
|
Feb 14, 2023 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 9 TO THE SCHEDULE 13G |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 10, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 10, 2023 |
|
SC 13G |
Report
|
SC 13G |
Jan 27, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Jan 26, 2023 |
|
SC 13G |
Report
|
PIERIS PHARMACEUTICALS, INC. |
Oct 24, 2022 |
|
SC 13G/A |
Report
|
|
Feb 14, 2022 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 8 TO THE SCHEDULE 13G |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
PIERIS PHARMACEUTICALS, INC. |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
AMENDMENT NO.1 TO SCHEDULE 13G |
Feb 14, 2022 |
|
SC 13G |
Report
|
SC 13G |
Jan 27, 2022 |
|
SC 13G/A |
Report
|
|
Jul 12, 2021 |
|
SC 13G |
Report
|
PIERIS PHARMACEUTICALS, INC. |
Jul 6, 2021 |
|
SC 13G |
Report
|
SC 13G |
Apr 8, 2021 |
|
SC 13G |
Report
|
SC 13G |
Apr 2, 2021 |
|
SC 13G/A |
Report
|
|
Feb 16, 2021 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 7 TO THE SCHEDULE 13G |
Feb 12, 2021 |
|
SC 13G/A |
Report
|
|
Jan 29, 2021 |
|
SC 13G/A |
Report
|
|
Apr 22, 2020 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 6 TO THE SCHEDULE 13G |
Feb 19, 2020 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 5 TO THE SCHEDULE 13G |
Feb 14, 2020 |
|
SC 13G/A |
Report
|
|
Feb 14, 2020 |
|
SC 13G |
Report
|
|
Feb 7, 2020 |
|
SC 13G |
Report
|
|
Nov 14, 2019 |
|
SC 13G |
Report
|
|
Oct 7, 2019 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 4 TO THE SCHEDULE 13G |
Feb 14, 2019 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 3 TO THE SCHEDULE 13G |
Jul 12, 2018 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 2 TO THE SCHEDULE 13G |
Feb 14, 2018 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 12, 2018 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 1 TO THE SCHEDULE 13G |
Feb 14, 2017 |
|
SC 13G/A |
Report
|
LOMBARD ODIER ASSET MANAGEMENT (USA) CORP |
Feb 14, 2017 |
|
SC 13G/A |
Report
|
SCHEDULE 13G AMENDMENT NO. 1 |
Feb 14, 2017 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 13, 2017 |
|
SC 13G/A |
Report
|
FORM SC 13G/A |
Jan 25, 2017 |
|
SC 13G |
Report
| Data |
THE SCHEDULE 13G |
Jun 17, 2016 |
|
SC 13G |
Report
|
PIERIS PHARMACEUTICALS, INC. |
Feb 16, 2016 |
|
SC 13G |
Report
|
SC 13G |
Feb 12, 2016 |
|
SC 13G |
Report
|
FORM SC 13G |
Jan 28, 2016 |
|
SC 13G/A |
Report
|
SC 13G/A |
Nov 24, 2015 |
|
SC 13G |
Report
|
0001583648 |
Sep 11, 2015 |
|
SC 13G |
Report
|
SC 13G |
Jul 10, 2015 |
|